4 different filers disclosed ORCL within 90 days. Disclosed 13 days after the transaction; reported as an official range, not an exact amount.
Traded Feb 9, 2026 · Filed Feb 11, 2026
The boss of Oracle sold $1.55M of Oracle shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,552,318
Shares × reported transaction price
61 days after results of Dec 10, 2025, 29 days before results of Mar 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $156.59 on Feb 9, 2026, 28% above its 52-week low and 52% below its high, after a 21% drop over the previous 30 trading days
52-week range $122.82 (Apr 21, 2025) to $328.33 (Sep 10, 2025), 16% of the way up, from 251 adjusted closes. 30 trading days earlier: $197.49 on Dec 24, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 3, 2026 in the U.S. District Court, D. Delaware. A filing is an allegation, not a finding.
Barrows v. Oracle Corporation, docket 1:26-cv-00127, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.0% | +0.5% | -0.4% |
| 30 days | -0.3% | -1.8% | +1.5% |
| 90 days | +21.3% | +9.0% | +12.3% |
| 180 days | -7.0% | +13.1% | -20.1% |
Past results only. Not a forecast.
4 different filers disclosed ORCL within 90 days. Disclosed 13 days after the transaction; reported as an official range, not an exact amount.
3 different filers disclosed ORCL within 90 days. Disclosed 14 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.